Ziopharm and Precigen Redefine Relationships, Announce New License Agreement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Intrexon (XON) PT Raised to $43 at JMP Securities
October 9, 2018 5:05 PM EDTJMP Securities analyst Jason Butler raised the price target on Intrexon (NASDAQ: XON) to $43.00 (from $42.00) while maintaining a Market Outperform rating after the company regains rights to large majority of cancer therapeutics portfolio.
... More